- Headquarters
- Gaithersburg, Maryland, United States · North America
- Value chain
- Medicines & vaccines(Products); also Research & IP
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 1987
- Ownership
- Listed
- Listing
- Nasdaq:NVAX on Google Finance
- Website
- novavax.com
- Relevance
- Moderate at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
Gaithersburg, Maryland, United StatesIn 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Design · listed #26 of 50
Developer of the recombinant protein Nuvaxovid COVID-19 vaccine and the Matrix-M adjuvant used in the R21 malaria vaccine; licensed its vaccine to Sanofi in 2024.
Relevance: Recombinant protein vaccine developer